- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 219-233 of
1,261 results
No. 22-10
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-10 (N.D.W.Va. May. 6, 2022)
|
|
Cite Document
No. 22-8
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-8 (N.D.W.Va. May. 6, 2022)
|
|
Cite Document
No. 22-1
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-1 (N.D.W.Va. May. 6, 2022)
|
|
Cite Document
No. 22-2
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-2 (N.D.W.Va. May. 6, 2022)
|
|
Cite Document
No. 22-6
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-6 (N.D.W.Va. May. 6, 2022)
|
|
Cite Document
No. 22-4
Document
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc., 1:22-cv-00023, No. 22-4 (N.D.W.Va. May. 6, 2022)
|
|
Cite Document
... of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2024 Exhibit - EX2024 Excerpt of Opening Expert Report of Dr John Bantle Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 030
|
|
Cite Document
... of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 ...
Document
IPR2024-00009, No. 2026 Exhibit - EX2026 Excerpt of Opening Expert Report of Dr Paul Dalby Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22 MD 0303
|
|
Cite Document
1098 Exhibit: District Court Order re Trial Date
Document
IPR2024-00009, No. 1098 Exhibit - District Court Order re Trial Date (P.T.A.B. Mar. 29, 2024)
|
|
Cite Document
1099 Exhibit: Proposed Stipulation
Document
IPR2024-00009, No. 1099 Exhibit - Proposed Stipulation (P.T.A.B. Mar. 29, 2024)
|
|
Cite Document
3001 Exhibit: Exhibit 3001
Document
IPR2024-00009, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Feb. 13, 2024)
|
|
Cite Document
2001 Exhibit: EX2001 Excerpt of Defendants’ Initial Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,1...
Document
IPR2024-00009, No. 2001 Exhibit - EX2001 Excerpt of Defendants’ Initial Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8,920,383 9,775,953 9,457,154 and 10,335,462, In
|
|
Cite Document
2018 Exhibit: EX2018 Excerpt of Defendants’ Supplemental Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8...
Document
IPR2024-00009, No. 2018 Exhibit - EX2018 Excerpt of Defendants’ Supplemental Invalidity Contentions Regarding US Patent Nos 8,129,343 8,536,122 8,114,833 8,920,383 9,775,953 9,457,154 and 10,335,462
|
|
Cite Document
2012 Exhibit: EX2012 Waiver of Service of Summons for Dr Reddy’s Laboratories, ...
Document
IPR2024-00009, No. 2012 Exhibit - EX2012 Waiver of Service of Summons for Dr Reddy’s Laboratories, Inc, Novo Nordisk Inc v Dr Reddy’s Lab’ys Ltd, No 122 cv 00298 CFC, Dkt 6 D Del, Mar 4,...
|
|
Cite Document
2009 Exhibit: EX2009 Joint Stipulation and Order Amending Scheduling Order, In r...
Document
IPR2024-00009, No. 2009 Exhibit - EX2009 Joint Stipulation and Order Amending Scheduling Order, In re Ozempic Semaglutide Patent Litigation, MDL No 22 MD 03038 CFC, Dkt 268 D Del Dec...
|
|
Cite Document
